4//SEC Filing
Ferrante Karen Jean 4
Accession 0000950170-25-001210
CIK 0001622229other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 4:21 PM ET
Size
5.7 KB
Accession
0000950170-25-001210
Insider Transaction Report
Form 4
Ferrante Karen Jean
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-01-01+2,785→ 2,785 totalExercise: $7.80From: 2025-01-01Exp: 2035-01-01→ Common Stock (2,785 underlying)
Footnotes (1)
- [F1]The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant.
Documents
Issuer
Cogent Biosciences, Inc.
CIK 0001622229
Entity typeother
Related Parties
1- filerCIK 0001598502
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 4:21 PM ET
- Size
- 5.7 KB